Sean E. Aeder

Array ( [id] => 6148722 [patent_doc_number] => 20110020317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'BREAST TUMOUR GRADING' [patent_app_type] => utility [patent_app_number] => 12/446195 [patent_app_country] => US [patent_app_date] => 2007-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 49715 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020317.pdf [firstpage_image] =>[orig_patent_app_number] => 12446195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5585965 [patent_doc_number] => 20090105167 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Predicting responsiveness to cancer therapeutics' [patent_app_type] => utility [patent_app_number] => 11/975722 [patent_app_country] => US [patent_app_date] => 2007-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 26279 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105167.pdf [firstpage_image] =>[orig_patent_app_number] => 11975722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6254463 [patent_doc_number] => 20100028881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'EXTRACELLULAR AND MEMBRANE-ASSOCIATED PROSTATE CANCER MARKERS' [patent_app_type] => utility [patent_app_number] => 12/442685 [patent_app_country] => US [patent_app_date] => 2007-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13114 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20100028881.pdf [firstpage_image] =>[orig_patent_app_number] => 12442685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4954914 [patent_doc_number] => 20080187938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'ALDH1 As A Cancer Stem Cell Marker' [patent_app_type] => utility [patent_app_number] => 11/859901 [patent_app_country] => US [patent_app_date] => 2007-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 18380 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20080187938.pdf [firstpage_image] =>[orig_patent_app_number] => 11859901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6629085 [patent_doc_number] => 20100004253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'BIOMARKERS OF TARGET MODULATION, EFFICACY, DIAGNOSIS AND/OR PROGNOSIS FOR RAF INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/441888 [patent_app_country] => US [patent_app_date] => 2007-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24334 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004253.pdf [firstpage_image] =>[orig_patent_app_number] => 12441888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8994767 [patent_doc_number] => 08518650 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-27 [patent_title] => 'Biomarkers for prostate cancer and methods using the same' [patent_app_type] => utility [patent_app_number] => 12/441945 [patent_app_country] => US [patent_app_date] => 2007-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 67813 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12441945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11881870 [patent_doc_number] => 09753035 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-05 [patent_title] => 'Array-based detection of genetic alterations associated with disease' [patent_app_type] => utility [patent_app_number] => 11/900648 [patent_app_country] => US [patent_app_date] => 2007-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 12 [patent_no_of_words] => 8349 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 194 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11900648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4965280 [patent_doc_number] => 20080108100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'Method of determining lymph node metastasis' [patent_app_type] => utility [patent_app_number] => 11/898294 [patent_app_country] => US [patent_app_date] => 2007-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13307 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20080108100.pdf [firstpage_image] =>[orig_patent_app_number] => 11898294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9254843 [patent_doc_number] => 08618260 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-31 [patent_title] => 'Tyrosine, serine and threonine phosphorylation sites' [patent_app_type] => utility [patent_app_number] => 12/310852 [patent_app_country] => US [patent_app_date] => 2007-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 31849 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12310852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4903947 [patent_doc_number] => 20080113360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Melanoma Gene Signature' [patent_app_type] => utility [patent_app_number] => 11/852102 [patent_app_country] => US [patent_app_date] => 2007-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 30618 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20080113360.pdf [firstpage_image] =>[orig_patent_app_number] => 11852102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8385949 [patent_doc_number] => 08263344 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-11 [patent_title] => 'Compounds regulating calreticulin, KDEL receptor and/or Erp-57 cell surface exposure and uses thereof to evaluate the efficiency of a cancer treatment' [patent_app_type] => utility [patent_app_number] => 12/438975 [patent_app_country] => US [patent_app_date] => 2007-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 56 [patent_no_of_words] => 22080 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 191 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12438975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4949401 [patent_doc_number] => 20080305527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Single Chain Pan ECTO-NOX Variable Region (ScFv) Antibody, Coding Sequence and Methods' [patent_app_type] => utility [patent_app_number] => 11/849170 [patent_app_country] => US [patent_app_date] => 2007-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6504 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20080305527.pdf [firstpage_image] =>[orig_patent_app_number] => 11849170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5323466 [patent_doc_number] => 20090061456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'Method for predicting progression free and overall survival at each follow-up time point during therapy of metastatic breast cancer patients using circulating tumor cells' [patent_app_type] => utility [patent_app_number] => 11/897504 [patent_app_country] => US [patent_app_date] => 2007-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6854 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20090061456.pdf [firstpage_image] =>[orig_patent_app_number] => 11897504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4928085 [patent_doc_number] => 20080167448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'Antibodies to tumor associated proteins' [patent_app_type] => utility [patent_app_number] => 11/842016 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 58 [patent_no_of_words] => 126909 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11842016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6289929 [patent_doc_number] => 20100158916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'DIAGNOSTIC BIOMOLECULE(S)' [patent_app_type] => utility [patent_app_number] => 12/440004 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12607 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158916.pdf [firstpage_image] =>[orig_patent_app_number] => 12440004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9020170 [patent_doc_number] => 08530155 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-10 [patent_title] => 'Methods for diagnosis of common acute lymphoblastic leukemia by determining the level of gene expression' [patent_app_type] => utility [patent_app_number] => 12/377863 [patent_app_country] => US [patent_app_date] => 2007-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 74 [patent_figures_cnt] => 34 [patent_no_of_words] => 15539 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 242 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12377863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11284806 [patent_doc_number] => 09500656 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-22 [patent_title] => 'Methods for the identification, assessment, and treatment of patients with cancer therapy' [patent_app_type] => utility [patent_app_number] => 11/891213 [patent_app_country] => US [patent_app_date] => 2007-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 44446 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11891213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6254450 [patent_doc_number] => 20100028876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'DIAGNOSTIC TESTS USING GENE EXPRESSION RATIOS' [patent_app_type] => utility [patent_app_number] => 12/310179 [patent_app_country] => US [patent_app_date] => 2007-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21755 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20100028876.pdf [firstpage_image] =>[orig_patent_app_number] => 12310179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8188762 [patent_doc_number] => 08182997 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-22 [patent_title] => 'Prostate cancer related gene STYK1' [patent_app_type] => utility [patent_app_number] => 12/376714 [patent_app_country] => US [patent_app_date] => 2007-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 22713 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/182/08182997.pdf [firstpage_image] =>[orig_patent_app_number] => 12376714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4915168 [patent_doc_number] => 20080095768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => 'USE OF ALLOGENEIC EFFECTOR CELLS AND ANTI-CS1 ANTIBODIES FOR SELECTIVE KILLING OF MULTIPLE MYELOMA CELLS' [patent_app_type] => utility [patent_app_number] => 11/835260 [patent_app_country] => US [patent_app_date] => 2007-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7845 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20080095768.pdf [firstpage_image] =>[orig_patent_app_number] => 11835260 [rel_patent_id] =>[rel_patent_doc_number] =>)